XXII Century Group Inc

22nd Century Group Inc is a plant biotechnology company. It is focused on technology that allow to increase or decrease the level of nicotine and other nicotinic alkaloids in tobacco plants and levels of cannabinoids in cannabis plants.

$1.78  -0.01 (-0.56%)
As of 05/23/2022 16:00:00 EST     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Consumer Staples
Industry:  Drug Manufacturers—Specialty &
Index country:  USA
Country of incorporation:  USA
IPO date:  01/26/2011
Outstanding shares:  164,536,566
Average volume:  1,547,676
Market cap:   $294,520,453
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      B1FH4T9

---

Valuation   (See tab for details)

---

PE ratio:   -8.02
PB ratio:   5.06
PS ratio:   8.87
Return on equity:   -62.96%
Net income %:   -109.97%